ArticleEuropean archives of psychiatry and clinical neuroscience2026
Anomalous self-experiences in biotypes of psychosis.
Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biotypes of psychoses represent transdiagnostic clusters based on pathological characteristics relevant to this syndrome. This approach seeks to help with the delimitation of groups with external validity within the psychotic syndrome beyond current categories. Our group has previously proposed two biotypes characterized by different cognitive performance and anatomical and functional alterations. Here, we propose that these groups may also differ in the presence and/or severity of anomalous self-experiences. We included 113 patients with psychotic disorders, classified as biotypes into clusters 1 (n = 30, with severe cognitive deficit) and 2 (n = 83, with moderate cognitive deficit) according to criteria established in previous studies (Comparelli et al in Compr Psychiatry 65:44-49, 2016) and (Nelson et al in Schizophr Res 152:20-27) healthy controls. The Inventory of Psychotic-Like Anomalous Self-Experiences (IPASE) was used to score anomalous self-experiences. Cluster 1 patients (severe cognitive impairment) showed significantly higher IPASE scores than healthy controls and Cluster 2 patients, whereas differences between Cluster 2 patients and healthy controls were less pronounced. We conclude that severe anomalous self-experiences characterize the biotype 1 of psychoses, alongside marked cognitive deficits, anatomical alterations, functional basal hyperactivity and higher negative symptoms scores.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.